These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056 [TBL] [Abstract][Full Text] [Related]
3. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341 [TBL] [Abstract][Full Text] [Related]
4. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311 [TBL] [Abstract][Full Text] [Related]
9. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis. Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239 [TBL] [Abstract][Full Text] [Related]
10. Arsenic-induced anti-angiogenesis via miR-425-5p-regulated CCM3. Gao Y; Yin Y; Xing X; Zhao Z; Lu Y; Sun Y; Zhuang Z; Wang M; Ji W; He Y Toxicol Lett; 2016 Jul; 254():22-31. PubMed ID: 27132035 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of CCM3 promotes angiogenesis through activation and nuclear translocation of YAP/TAZ. Tang L; Zhou M; Xu Y; Peng B; Gao Y; Mo Y Biochem Biophys Res Commun; 2024 Mar; 701():149525. PubMed ID: 38320423 [TBL] [Abstract][Full Text] [Related]
14. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth. Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477 [TBL] [Abstract][Full Text] [Related]
15. RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain. Bridges E; Sheldon H; Kleibeuker E; Ramberger E; Zois C; Barnard A; Harjes U; Li JL; Masiero M; MacLaren R; Harris A Angiogenesis; 2020 Aug; 23(3):493-513. PubMed ID: 32506201 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870 [TBL] [Abstract][Full Text] [Related]
17. A novel peptide inhibitor of Dll4-Notch1 signalling and its pro-angiogenic functions. Zhu G; Lin Y; Ge T; Singh S; Liu H; Fan L; Wang S; Rhen J; Jiang D; Lyu Y; Yin Y; Li X; Benoit DSW; Li W; Xu Y; Pang J Br J Pharmacol; 2022 Apr; 179(8):1716-1731. PubMed ID: 34796471 [TBL] [Abstract][Full Text] [Related]
18. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes. Schulz GB; Wieland E; Wüstehube-Lausch J; Boulday G; Moll I; Tournier-Lasserve E; Fischer A Stroke; 2015 May; 46(5):1337-43. PubMed ID: 25791711 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Williams CK; Li JL; Murga M; Harris AL; Tosato G Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802 [TBL] [Abstract][Full Text] [Related]
20. PDCD10-Deficiency Promotes Malignant Behaviors and Tumor Growth via Triggering EphB4 Kinase Activity in Glioblastoma. Wan X; Saban DV; Kim SN; Weng Y; Dammann P; Keyvani K; Sure U; Zhu Y Front Oncol; 2020; 10():1377. PubMed ID: 32850441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]